Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Maxwell John T.
Relationship:   Chief Financial Office...
City:   Warren
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   591,207    

Indirect Shares

  36,757      
Direct Value   $438,287    

Indirect Value

  $0      
Total Shares   627,964      
Total Value   $438,287      


Aquestive Therapeutics, Inc.
 $438,287 Wejo Group Ord Shs
 $0 Aquestive Therapeutics, Inc.
 $438,287 Wejo Group Ord Shs
 $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Aquestive Therapeutics, Inc. AQST 2020-08-18 150,614 2018-11-21 0    Premium*  
            Wejo Group Ord Shs WEJO Chief Financial Office... 2022-11-19 440,593 2022-11-19 36,757    Premium*  
* Premium Members only  

Records found :    6         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
WEJO Wejo Group Ord Shs Chief Financial Officer   •       •      –    2022-11-19 4 D $0.84 $62,543 D/D (74,456) 440,593 0 -
WEJO Wejo Group Ord Shs Chief Financial Officer   •       •      –    2022-07-27 4 A $1.36 $50,001 D/D 36,757 515,049 0 -
WEJO Wejo Group Ord Shs Chief Financial Officer   •       •      –    2022-07-27 4 A $1.36 $50,001 I/I 36,757 36,757 0 -
AQST Aquestive Therapeutics, I... SVP-Chief Financial Officer   •       –      –    2020-08-18 4 AS $8.00 $24,000 D/D (3,000) 150,614 0 %
AQST Aquestive Therapeutics, I... SVP-Chief Financial Officer   •       •      –    2018-12-06 4 B $8.87 $44,350 D/D 5,000 153,614 0.01 -
AQST Aquestive Therapeutics, I... SVP-Chief Financial Officer   •       •      –    2018-11-21 4 B $9.80 $98,000 D/D 10,000 148,614 0.01 -

  6  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed